Continuous activation of LRP5 may have additive toxicity resulting from the control of multiple genes and promote tissue fibrosis [56–58], various types of cancer and tumor metastasis [59,60], valve degeneration and calcification [61,62], and osteoarthritis [63,64]. The gene discussed is LRP5; the disease is cancer.